Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03689465
What this trial is testing

PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 260
Testing effectiveness (Phase 2)Study completedNCT02867384
What this trial is testing

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft vs. Host Disease
Dana-Farber Cancer Institute 181
Early research (Phase 1)UnknownNCT00517907
What this trial is testing

Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)

Who this might be right for
Graft Vs Host Disease
Hadassah Medical Organization 6
Not applicableLooking for participantsNCT05170347
What this trial is testing

OGVHD After Bone Marrow Transplantation: a Territory-wide Cohort

Who this might be right for
Graft Vs Host DiseaseHaematological MalignancyCancer
The University of Hong Kong 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Not applicableLooking for participantsNCT05124288
What this trial is testing

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Who this might be right for
Acute Myeloid Leukemia, in Relapse
Ciceri Fabio 500
Post-approval studies (Phase 4)UnknownNCT04203108
What this trial is testing

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 266
Testing effectiveness (Phase 2)Ended earlyNCT01220297
What this trial is testing

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Who this might be right for
Hematologic DiseasesAcute-graft-versus-host DiseaseLeukemia+2 more
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT02337595
What this trial is testing

Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteImmune Deficiency Disease+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Testing effectiveness (Phase 2)Study completedNCT00803010
What this trial is testing

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 74
Testing effectiveness (Phase 2)Study completedNCT02876679
What this trial is testing

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

Who this might be right for
Graft vs Host Disease
Assistance Publique - Hôpitaux de Paris 94
Testing effectiveness (Phase 2)Looking for participantsNCT06859424
What this trial is testing

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
AML (Acute Myelogenous Leukemia)Acute Lymphoid Leukemia (ALL)Acute Leukemia (Category)+8 more
Center for International Blood and Marrow Transplant Research 358
Not applicableUnknownNCT04372524
What this trial is testing

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

Who this might be right for
Chronic Graft-versus-Host-DiseaseLeukemiaAllogeneic Hematopoietic Stem Cell Transplantation+2 more
University of British Columbia 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT02669251
What this trial is testing

Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host DiseaseBronchiolitis Obliterans Syndrome
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Looking for participantsNCT07006506
What this trial is testing

Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseGraft Vs Host DiseaseHematologic Malignancy
Memorial Sloan Kettering Cancer Center 46
Large-scale testing (Phase 3)Study completedNCT01231412
What this trial is testing

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more
Fred Hutchinson Cancer Center 174
Post-approval studies (Phase 4)Looking for participantsNCT07569653
What this trial is testing

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus DiseaseHematopoietic Stem Cell Transplantation+1 more
WeiShi 120
Post-approval studies (Phase 4)Study completedNCT00003398
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
AnemiaGraft Versus Host DiseaseLeukemia+3 more
University of Maryland, Baltimore 45
Testing effectiveness (Phase 2)Study completedNCT00429416
What this trial is testing

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)UnknownNCT01765634
What this trial is testing

Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease

Who this might be right for
Acute Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 40
Next Page